Boardroom Alpha
Meeting calendar
CRM · Annual meeting · Thursday, May 28, 2026

Salesforce Inc

13 nominees · 6 ballot items.

Election of 13 directors; amend and restate 2013 Equity Incentive Plan to add 34M shares and extend term; amend and restate 2004 Employee Stock Purchase Plan to add 20M shares; ratify Ernst & Young LLP as independent auditor; advisory approval of named executive officer compensation (say-on-pay); stockholder proposal to adopt cumulative voting.

Market cap
$136.8B
1Y TSR
-38.8%
Board grade
C+
Record date
Apr 6, 2026
Filing
DEF 14A
Meeting concluded · May 28, 2026

Follow how the vote landed and what changed on Salesforce Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot6

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect 13 nominees — Marc Benioff, Laura Alber, Amy Chang, Craig Conway, Arnold Donald, Parker Harris, David B. Kirk, Neelie Kroes, Sachin Mehra, Mason Morfit, Oscar Munoz, John V. Roos, and Robin Washington — to serve as directors.

  2. 2

    Amendment and Restatement of the Company’s 2013 Equity Incentive Plan

    ManagementBoard: FOR

    Amend and restate the 2013 Equity Incentive Plan to increase the share reserve by 34 million shares, extend the plan term, remove minimum one-year vesting provision, and align exchange program definitions.

    More detail

    The proposal seeks shareholder approval to amend and restate the 2013 Equity Incentive Plan to add 34 million shares to the plan reserve, extend the plan termination date by one year, eliminate the prior general one-year minimum vesting requirement, and update definitions related to exchange programs to align with repricing rules. Management frames the request as necessary to sustain a broad-based equity program crucial for attracting and retaining specialized AI and cloud talent during a competitive market, and to enable continued grant activity for roughly one to two years based on forecasts. The company emphasizes responsible dilution management through disciplined grant practices, fungible-share counting (2.15-for-1 for full-value awards), a three-year average burn rate of 1.5%, and large share repurchases (including a $25B accelerated repurchase) that have reduced outstanding shares net of grants. The removal of minimum vesting provides flexibility to implement market-competitive vesting schedules (e.g., cliff-free awards) used by peers, aimed at reducing hiring friction and retention risk, while other plan provisions preserve anti-repricing protections and annual award limits for executives and non-employee directors. If approved, the amendment becomes effective upon shareholder vote; if not, the plan remains in its current form. The board recommends a FOR vote, citing alignment, governance safeguards, and the program’s role in talent strategy and long-term value creation.

  3. 3

    Amendment and Restatement of the Company’s 2004 Employee Stock Purchase Plan

    ManagementBoard: FOR

    Amend and restate the 2004 ESPP to increase shares reserved for issuance by 20 million shares and make clerical updates; continue offering employees discounted purchase opportunities.

    More detail

    Management asks shareholders to approve adding 20 million shares to the 2004 Employee Stock Purchase Plan (ESPP) reserve to ensure the plan can continue to facilitate employee purchases of stock at a discount and sustain participation rates. The ESPP is presented as a critical retention and ownership tool, with historical purchase volumes of 3.5M, 3.4M, and 5.9M shares in fiscal years 2026, 2025, and 2024, respectively. If approved, total ESPP authorization rises to 81M shares; without approval, the ESPP’s available shares (approx. 10.1M as of March 25, 2026) are expected to be exhausted within about a year. The Board emphasizes that ESPP participation aligns employee incentives with stockholder interests, and that expanding the reserve is preferable to other compensation mechanisms. The board recommends a FOR vote.

  4. 4

    Ratification of Appointment of Ernst & Young LLP

    ManagementBoard: FOR

    Ratify EY as the Company’s independent registered public accounting firm for fiscal 2027.

    More detail

    The Audit Committee recommends ratification of Ernst & Young LLP (EY) as the independent registered public accounting firm for fiscal 2027 following a comprehensive annual review of audit quality, independence, fees, tenure, and EY’s capability to handle the company’s global operations and complex accounting matters. The committee considered PCAOB reports, partner rotation, and EY’s familiarity with Salesforce’s financial systems and internal controls. The company discloses audit and non-audit fees and confirms pre-approval procedures for services. Ratification is non-binding but viewed as good governance; the Audit Committee can replace EY if needed. The board recommends a FOR vote.

  5. 5

    Advisory Vote to Approve Named Executive Officer Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding advisory vote to approve fiscal 2026 named executive officers’ compensation as disclosed in the proxy.

    More detail

    This proposal asks shareholders to cast a non-binding advisory vote to approve the disclosed fiscal 2026 compensation for Named Executive Officers. Management summarizes that the program was redesigned for fiscal 2026 to emphasize performance-based equity (PRSUs and performance options tied to Agentforce & Data 360 ARR and Margin & Growth), link annual bonuses to revenue and non-GAAP operating income with strategic modifiers, and increase stock ownership requirements. The Compensation Committee highlights robust stockholder engagement, balanced metrics (rTSR and Margin & Growth), and measures to manage dilution and governance, including clawbacks and capped payouts. The Board recommends a FOR vote, noting the program’s alignment with strategy, retention, and pay-for-performance objectives.

  6. 6

    Stockholder Proposal Requesting the Adoption of Cumulative Voting

    Shareholder — National Legal and Policy CenterBoard: AGAINST

    Stockholder proposal by National Legal and Policy Center requesting the board adopt cumulative voting for director elections by amending charter and bylaws.

    More detail

    The shareholder proponent (NLPC) requests adoption of cumulative voting to strengthen shareholder rights by permitting allocation of votes among director nominees, which can assist minority shareholders in securing board representation. Management strongly opposes the proposal, arguing Salesforce already provides proportional voting rights, annual director elections, proxy access, majority voting in uncontested elections, and other governance mechanisms; the board warns cumulative voting could enable small minority stockholders to elect directors unrepresentative of the broader shareholder base and cause board fragmentation. The Board notes the practice is uncommon among large-cap companies (less than 2% of S&P 500) and recommends against the proposal.

Director elections

Nominees on the ballot13

Independent
Tenure on this board
4.6 yrs
Also a director at
Williams Sonoma Inc (WSM)
Independent
Tenure on this board
1.0 yrs
Also a director at
Procter & Gamble Co (PG)Walt Disney Co (DIS)
Craig Conway
Independent
Tenure on this board
New nominee
Independent
Tenure on this board
3.4 yrs
Also a director at
Bank Of America Corp (BAC)Mp Materials Corp (MP)Ge Vernova Inc (GEV)
Independent
Tenure on this board
4.5 yrs
Also a director at
Archer Aviation Inc (ACHR)
Not independent
Tenure on this board
12.8 yrs
Also a director at
Alphabet Inc (GOOGL)
Ownership

Top institutional holders10

Latest 13F quarter
1VANGUARD CAPITAL MANAGEMENT LLC7.2%59,333,776$11.1B
2STATE STREET CORP6.0%48,953,388$9.1B
3BlackRock, Inc.3.9%32,291,825$6.0B
4VANGUARD PORTFOLIO MANAGEMENT LLC2.4%19,419,407$3.6B
5BlackRock, Inc.2.4%19,341,613$3.6B
6GEODE CAPITAL MANAGEMENT, LLC2.3%19,222,920$3.6B
7Capital World Investors2.0%16,711,525$3.1B
8HARRIS ASSOCIATES L P1.8%14,649,101$2.7B
9Capital Research Global Investors1.7%13,705,564$2.6B
10ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.5%12,659,217$2.4B
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Salesforce Inc 2026 annual meeting?
Salesforce Inc (CRM) holds its 2026 annual shareholder meeting on Thursday, May 28, 2026.
What is the record date for the Salesforce Inc 2026 meeting?
The record date for the Salesforce Inc 2026 meeting is Monday, April 6, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Salesforce Inc's 2026 meeting?
The board is presenting 13 director nominees at the Salesforce Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Salesforce Inc 2026 meeting?
Shareholders will vote on 6 proposals at the Salesforce Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer